Spruce Biosciences (SPRB) EPS (Diluted) (2021 - 2026)
Spruce Biosciences (SPRB) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.15 |
| 10 | Spruce Biosciences | 125.93 Mn | 125.93 Mn | - | -6.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.41 |
| Mar 31, 2026 | -15.77 |
| Dec 31, 2025 | -14.51 |
| Sep 30, 2025 | -14.58 |
| Jun 30, 2025 | -3.50 |
| Mar 31, 2025 | -24.24 |
| Dec 31, 2024 | -42.68 |
| Sep 30, 2024 | -15.75 |
| Jun 30, 2024 | -16.73 |
| Mar 31, 2024 | -21.22 |
| Dec 31, 2023 | -21.95 |
| Sep 30, 2023 | -25.29 |
| Jun 30, 2023 | -25.84 |
| Mar 31, 2023 | -30.68 |
| Dec 31, 2022 | -32.20 |
| Sep 30, 2022 | -38.73 |
| Jun 30, 2022 | -39.74 |
| Mar 31, 2022 | -38.94 |
| Dec 31, 2021 | -30.90 |
| Sep 30, 2021 | -59.40 |